Arrowhead Pharmaceuticals, Inc.
ARWR
$16.97
-$0.70-3.96%
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -18.69% | 55.93% | -16.59% | 144.13% | -46.08% |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | -1.79% | 3.58% | -16.47% | 4.81% | 19.32% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -7.53% | 32.72% | -34.28% | -30.63% | 17.36% |
| Total Current Assets | -17.96% | 54.53% | -16.91% | 127.68% | -42.88% |
|
|
|||||
| Total Current Assets | -17.96% | 54.53% | -16.91% | 127.68% | -42.88% |
| Net Property, Plant & Equipment | 0.15% | 2.63% | 4.05% | 6.76% | 12.74% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -4.96% | -4.73% | -4.52% | -4.32% | -4.14% |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -31.21% | 0.49% | 2,023.81% | -9.48% | -92.88% |
| Total Assets | -11.06% | 28.97% | -7.47% | 52.51% | -18.19% |
|
|
|||||
| Total Accounts Payable | 26.95% | -57.11% | 211.58% | 91.05% | -87.56% |
| Total Accrued Expenses | -15.72% | 42.29% | 30.45% | -1.27% | 0.94% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 29.06% | 4.77% | 14.53% | 54.49% | -67.61% |
| Total Finance Division Other Current Liabilities | -35.02% | -36.69% | -6.53% | -33.30% | -23.42% |
| Total Other Current Liabilities | -35.02% | -36.69% | -6.53% | -33.30% | -23.42% |
| Total Current Liabilities | -9.12% | 6.67% | 48.39% | 2.28% | -39.57% |
|
|
|||||
| Total Current Liabilities | -9.12% | 6.67% | 48.39% | 2.28% | -39.57% |
| Long-Term Debt | 2.73% | 118.59% | 19.61% | 2.65% | 2.00% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -1.56% | -0.90% | -1.40% | -1.32% | 10.08% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 0.94% | 74.15% | 18.50% | 1.58% | -5.40% |
|
|
|||||
| Common Stock & APIC | 2.26% | 1.10% | 0.99% | 33.97% | 1.53% |
| Retained Earnings | -10.65% | -11.72% | -13.30% | -10.81% | -12.95% |
| Treasury Stock & Other | -12.91% | 581.26% | 9.86% | 12.75% | 61.05% |
| Total Common Equity | -71.64% | -43.90% | -31.68% | 201.60% | -40.88% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -71.64% | -43.90% | -31.68% | 201.60% | -40.88% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -37.96% | -33.32% | -27.42% | -12.75% | -15.88% |
| Total Equity | -70.65% | -43.63% | -31.58% | 185.18% | -39.51% |
|
|
|||||
